uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 07/08/2026New research published in 𝘜𝘳𝘰𝘨𝘺𝘯𝘦𝘤𝘰𝘭𝘰𝘨𝘺 found that chlorhexidine vaginal prep was associated with 60% lower odds of surgical site infection within 30 days compared with iodine prep. Read: loom.ly/8QSRfks 111
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 17/07/2026New research from Dr. Roberts, published in Urogynecology, found remote follow-up after urogynecologic surgery provides outcomes comparable to in-office visits, supporting telemedicine as a safe, effective, patient-centered approach to postoperative care. ➡️ loom.ly/3Pb6sZo 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 16/07/2026Drs. Ackroyd & Lee recently published in the International Journal of Gynecologic Cancer, highlighting the importance of shared decision-making and patient-centered care in advanced and recurrent uterine cancer. Read ➡️ bit.ly/3T0nLwd @uchicagocancer.bsky.social 001
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 16/07/2026Drs. Perinchery and Christmas published "Midlife Vulvovaginal and Sexual Health" in Obstetrics and Gynecology Clinics of North America. Their review highlights evidence-based approaches to improving vulvovaginal and sexual health during menopause. Read ➡️ bit.ly/4vDHlMe 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 16/07/2026New research from the Lengyel Laboratory is featured on the cover of the June issue of Trends in Pharmacological Sciences. The invited review explores how advances in NNMT biology & inhibitor development are accelerating progress toward new therapies. ➡️ loom.ly/eoXA2QU 011
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 08/07/2026Congratulations to Drs. Mills & Medved on their selection to receive funding through the Gray Foundation's prestigious Team Science Program. Their collaboration will develop advanced MRI & AI tools for the early detection of BRCA-associated cancers. Learn more: t.co/QzJDp2W3UT 010
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 23/06/2026Congrats to the OB/GYN Residency Class of 2026! As they begin the next chapter of their careers, we are proud to celebrate all they have accomplished & excited to see the impact they will make in the future. 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 12/06/2026New review by Dr. Abramowicz, published in the American Journal of Perinatology, explores how prenatal ultrasound can help identify and monitor complications associated with diabetes in pregnancy. Read: loom.ly/6dgcFKY 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 12/06/2026Drs. Griffith, Christmas, & Farina published a research letter in JAMA Network Open finding a substantial increase in online searches related to commercial menopause products & services over the past 2 decades, highlighting the importance of evidence-based menopause information. loom.ly/6OD9h5s 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 11/06/2026Drs. Altwerger & Griffith published a study in Gynecologic Oncology Reports showing reduced-dose lenvatinib was associated w/ higher response rates & improved tolerability in patients w/ recurrent endometrial cancer, including those with platinum-resistant & high-grade disease. Read: bit.ly/3Qk57OP 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 20/04/2026German Consul Michael Ahrens visited Dr. Lengyel’s lab, met with his team, & learned more about their translational research, including work by DFG-funded residents Franziska Ganster (LMU Munich) & Charlotte Sachs (UKE Hamburg), who are studying ovarian cancer biology with us. 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 01/04/2026Congratulations to Drs. Perpetua Goodall and Shari Snow on their induction into the Academy of Clinical Excellence, honoring BSD clinicians who set the highest standard in patient care, leadership, and integrity. Please join us in congratulating them along with the other 27 inductees. 000
Reposted by @uchicagoobgyn.bsky.socialOncLive @onclive.bsky.social · 10/03/2026📹 Katherine Kurnit, MD, and John Moroney, MD, of @uchicagocancer.bsky.social discuss the importance of timing in gynecologic cancer clinical trials. #oncology #medtwitter #gynecologiccancer 👉Watch here: www.onclive.com/view/dissect...onclive.comDissecting the Importance of Timing in Gynecologic Cancer Clinical Trials | OncLiveJohn Moroney, MD, and Katherine Kurnit, MD, MPH, emphasize the importance of timing in gynecologic cancer clinical trials. 033
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 13/03/2026We're hosting a hands-on CME event on Saturday, April 18th, from 9 am - 2 pm: Advances in the Management of Benign Gynecologic Conditions. See the flier for event learning objectives and key takeaways. Space is limited. Register today: loom.ly/OfzQfqw 010
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 27/02/2026New publication in Urogynecology from Drs. Mueller, Griffith & Kenton! This federally funded multicenter study validates a simple, patient-centered question to assess recovery after pelvic floor surgery: “To what extent do you feel physically recovered after surgery?” Read: loom.ly/J_IuobI 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 27/02/2026Happy #ThankAResidentAndFellowDay! Our department is fortunate to have 31 exceptional residents and 14 outstanding fellows whose contributions touch every part of our department. We are so grateful for all of their hard work and dedication! 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 26/02/2026New research from the Al-Hendy Lab, published in Endocrine Reviews, highlights emerging evidence that vitamin D sufficiency may reduce uterine fibroid risk and could offer a promising nonhormonal approach to help stabilize fibroid growth and symptoms. Read more: loom.ly/nYgxbXI 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 20/02/2026UChicago Medicine OB/GYN had an outstanding presence at the 2026 Society for Maternal-Fetal Medicine Annual Meeting, with faculty, fellows, residents and medical students contributing across poster sessions and expert forums. #SMFM #SMFM26 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 17/02/2026New gynecologic oncology research from Dr. Gary Altwerger and colleagues: chemo outcomes, minimally invasive surgical techniques, and innovative approaches to complex clinical challenges in HIPEC. Links in the thread below. #UChicagoMedicine #UChicago #GynOnc 310
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 13/02/2026New in Gynecologic Oncology: Dr. Han Cun’s review “Radiation Therapy for the Gynecologic Oncologist” highlights advances in IMRT, SBRT, proton therapy and brachytherapy. Read: loom.ly/oajs9U0 #GynecologicOncology #GynOnc #UChicagoMedicine 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 12/02/2026New research by Drs. Collins and Kenton is currently featured on the @jamainternalmed.com homepage. This AHRQ-funded study shows that automated screening in primary care increases diagnosis and referral for urinary incontinence. Read: loom.ly/HWOwgj4 010
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 06/02/2026Drs. Perpetua Goodall and Shari Snow have been selected as 2026 inductees to the BSD Academy of Clinical Excellence (ACE). Their clinical excellence, commitment to equitable care and dedication to mentoring exemplify ACE’s values. Congratulations, Drs. Goodall and Snow! 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 03/02/2026UChicago Medicine Ingalls Memorial Hospital’s new women’s health clinic in Harvey expands OB/GYN care across Chicago’s Southland. Patients can access screenings, contraception, menopause care, fibroid/endometriosis treatment, high-risk pregnancy care and gynecologic oncology. 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 23/01/2026Proud to share that several UChicago Medicine OB/GYN physicians were named to Chicago magazine’s “Cancer Fighters” list. This honors the cutting-edge care and research happening across our department. Learn more: loom.ly/W80asWw 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 25/11/2025New publication: Dr. Jessica Long co-authored a chapter on ovarian tissue cryopreservation and transposition in the newly released Pediatric and Adolescent Gynecologic Surgery: Management, Surgical Approaches and Post-Operative Care. Learn more: loom.ly/93h5rKg 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 06/11/2025A new study led by Dr. Sandra Laveaux in the International Journal of Women's Health highlights what patients and providers prioritize when choosing medications for uterine fibroids. Findings support more personalized, patient-centered care through shared decision-making. Read: loom.ly/UjfKib0 010
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 30/10/2025New in F&S Science: UChicago OB/GYN researchers developed and validated a protocol for transvaginal shear wave elastography to measure uterine and leiomyoma stiffness. Read more: pubmed.ncbi.nlm.nih.gov/40934972/ 010
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 23/10/2025New RCT led by Dr. Kimberly Kenton, with co-author Dr. Sarah Collins, published in the American Journal of Gynecology, shows similar satisfaction at 2 vs. 6 weeks for resuming vaginal intercourse after retropubic sling. No mesh exposures and no difference in outcomes. Read: loom.ly/Tpg8wOU 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 22/10/2025Over 50 years, OB/GYN residents & faculty have undergone a near-complete reversal in gender composition. New study by Drs. Romero & Kenton projects that by 2035, <1% of OB/GYN residents may be male. Learn more: bit.ly/4666dkU 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 17/10/2025Dr. Kimberly Kenton coauthored ACOG’s new national curriculum for URPS: PROLOG: Urogynecology, 2nd Ed! Also featuring Dr. Sarah Ashmore (former Urogynecology Fellow) & Dr. Juraj Letko (Urogynecologist). Learn more: bit.ly/3HLQ788 #ObGyn #Urogynecology #UChicagoMedicine 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 15/10/2025We’re proud to recognize resident Drs. Neha Reddy and Samantha Neal (PGY3s) for their leadership in UCM’s GME Champion programs. Their work in community engagement and resident well-being exemplifies the mission of our department. #MedEd #OBGYN #ResidentLeadership 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 09/10/20252 new studies from Dr. Sarah Ackroyd & team: 1️⃣ In stage I–III endometrial cancer, no differences in survival by race or neighborhood disadvantage: loom.ly/v2cCbUk 2️⃣ In grade 3 tumors, no racial differences in HER2 or molecular subtype: loom.ly/sC7ZWMo 020
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 01/10/2025Planning a pregnancy or pregnant with IBD? UChicago Medicine now offers a dedicated clinic where MFM + GI specialists work together to support you every step of the way. Held monthly at DCAM. Talk to your provider about a referral. #IBD #PregnancyCare 010
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 30/09/2025New in Pediatric Annals: Drs. Jessica Long & Carrie Smith guest edited a special edition on Pediatric & Adolescent Gynecology. Their lead article, “Deciding Together,” explores the complexities of care for adolescents. Read here: bit.ly/48BJSyD #OBGYN #AdolescentHealth 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 29/09/2025New in Urogynecology: Dr. Maggie Mueller led an international AUGS panel to develop the first evidence-based consensus on postoperative activity after urogynecologic surgery. Key takeaway: Liberal activity is safe. Learn more: bit.ly/46F4xPN #Urogynecology #AUGS #WomensHealth 000
Reposted by @uchicagoobgyn.bsky.socialUChicago Cancer @uchicagocancer.bsky.social · 09/09/2025A new study published in @gynoncjnls shows that delivering care at high-resource tertiary centers may eliminate racial and socioeconomic disparities in women with treatable stage I-III endometrioid endometrial cancer. @uchicagoobgyn.bsky.social ow.ly/hWtP50WUb7Fow.lyRace and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center - PubMedIn women with Stage I-III EEC treated at a single tertiary referral center, we did not find differences in outcomes when analyzed by ADI or race. Given previously reported racial disparities in outcom... 011
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 25/08/2025New in @acadmedjournal.bsky.social: Dr. Sarah Wagner and colleagues share outcomes from a national “Readiness for Residency” curriculum supporting OB/GYN interns in building resilience, community and professional identity. Now adopted by CREOG programs nationwide. Read: bit.ly/3HJ1mOy @acog.org 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 12/08/2025Our recent publication by @lisaschweizer.bsky.social, @mpibiochem.bsky.social & @lengyel-ovca-lab.bsky.social is featured on the cover of @cp-cancercell.bsky.social! The artwork illustrates the malignant progression of borderline ovarian tumors to LGSOCs. Read: www.cell.com/cancer-cell/... 030
Reposted by @uchicagoobgyn.bsky.socialCancer Cell @cp-cancercell.bsky.social · 11/08/2025Leap onto the August issue of Cancer Cell, out now: www.cell.com/cancer-cell/... 052
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 25/07/2025New in Urogynecology: Dr. Juraj Letko and colleagues highlight uterine preservation as a safe, effective option in prolapse surgery, supporting patient-centered, evidence-based care. Read: pubmed.ncbi.nlm.nih.gov/40168462/ 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 24/07/2025New from UChicago OB/GYN: Drs. Perinchery (PGY3) and Mills review sentinel lymph node mapping in vulvar and cervical cancers in Gynecologic Oncology Reports, highlighting clinical evidence, surgical techniques and institutional insights. Read: www.sciencedirect.com/science/arti... #gynonc 000
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 23/07/2025New in @nature.com: Drs. @lengyel-ovca-lab.bsky.social, Janna Heide & co-authors discovered a first-of-its-kind NNMT inhibitor that reprograms cancer-associated fibroblasts and restores immune response in ovarian cancer. A major step toward more effective therapies. www.nature.com/articles/s41...nature.comNNMT inhibition in cancer-associated fibroblasts restores antitumour immunity - NatureAn NNMT inhibitor reduces tumour burden and metastasis in multiple mouse cancer models and restores immune checkpoint blockade efficacy by decreasing cancer-associated-fibroblast-mediated recruitment ... 021
Reposted by @uchicagoobgyn.bsky.socialUChicago Cancer @uchicagocancer.bsky.social · 23/07/2025🔥 Hot off the press: In a new @nature.com study, Ernst Lengyel, MD, PhD and team show that blocking NNMT in tumor-supporting cells restores immune response & stops ovarian cancer growth, offering a new strategy to treat one of the deadliest cancers. @lengyel-ovca-lab.bsky.social ow.ly/zzfZ50Wu3UW 022
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 03/07/2025Dr. Kimberly Kenton, Section Chief of Urogynecology & Reconstructive Pelvic Surgery, delivered two invited presentations at #IUGAEUGA2025 in Barcelona: a plenary session on cancer & pelvic floor health, & a masterclass in robotic urogynecology. #PelvicHealth #RoboticSurgery #WomensHealth 010
Reposted by @uchicagoobgyn.bsky.socialCancer Cell @cp-cancercell.bsky.social · 27/06/2025Online Now: Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progressiondlvr.itSpatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progressionSchweizer et al. profile the tumor progression from non-invasive serous borderline tumors of the ovary to metastatic low-grade serous ovarian cancer. By integrating cell-type resolved Deep Visual Proteomics and spatial transcriptomics, they identify and validate several drivers of transformation as well as a novel combination treatment for this chemo-resistant disease. 084
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 26/06/2025Join us in celebrating the UChicago OB/GYN Resident Class of 2025! Drs. Brockman, Byl, Hood, Hripko, Kar, Lamacki & Smith, thank you for your dedication to patient care, scholarship & leadership. We wish you all the best in the next chapter. #ResidencyGraduation 000
Reposted by @uchicagoobgyn.bsky.socialMax Planck Institute of Biochemistry @mpibiochem.bsky.social · 26/06/2025An interdisciplinary study uncovers how benign borderline ovarian tumors develop into invasive low-grade serous carcinoma, opening a new avenue for targeted therapy. ❕Publication: www.cell.com/cancer-cell/... ❕Press Release: www.biochem.mpg.de/when-tumors-... 144
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 26/06/2025A new publication in #CancerCell uncovers how borderline ovarian tumors evolve into low-grade serous ovarian cancer & identifies a promising new treatment strategy. www.sciencedirect.com/science/arti... @lisaschweizer.bsky.social @mannlab.bsky.social @lengyel-ovca-lab.bsky.socialsciencedirect.comSpatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progressionEpithelial serous borderline tumors (SBT) are non-invasive neoplastic ovarian lesions that may recur as chemo-resistant low-grade serous cancer (LGSC)… 020
Reposted by @uchicagoobgyn.bsky.socialMann Lab @mannlab.bsky.social · 26/06/2025Our paper on ovarian cancer #LGSC is out in @Cancer_Cell. Using deep visual proteomics #DVP and spatial transcriptomics, we mapped how non-invasive tumors become deadly ovarian disease, and found a promising new treatment combination. www.cell.com/cancer-cell/...cell.comSpatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progressionSchweizer et al. profile the tumor progression from non-invasive serous borderline tumors of the ovary to metastatic low-grade serous ovarian cancer. By integrating cell-type resolved Deep Visual Prot... 12310
uchicagoobgyn.bsky.social @uchicagoobgyn.bsky.social · 17/06/2025New study by Drs. Rivlin & Wascher in @jamanetworkopen.com: 42% of clinicians providing abortion practicing in ban states relocated post-Dobbs, most to states where abortion remains legal. These shifts threaten access to reproductive & maternal health care. Read: bit.ly/3HCxnYh 000
